Global Pharmaceutical Market Forecast to 2012

The pharmaceutical market worldwide, after having experienced exponential growth over the past few years, is now witnessing a slump. This decline in global pharma market is largely attributed to the patent expiry of key blockbusters together with saturation in key pharma markets such as the US and Western Europe. Meanwhile, pharma markets in some developing regions like Asia and Latin America have been continuously witnessing robust growth rate in last few years on account of increasing prevalence of diseases, rising healthcare spending and increasing affordability. Overall, these markets enjoy good growth potential in coming few years.

According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6% during 2010-2012. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market over the forecast period, indicating large opportunities for generics manufacturers to tap.

Our regional level analysis finds that the pharma industry is growing at a rapid rate in the emerging countries like India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides this, we have found that growing inorganically via means of Mergers & Acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenues. We anticipate this trend to continue in near future also.

“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific and Africa have been selected as the most important regions to be presented in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
[Studien Infos ausblenden]

1. Analyst View
2. Global Pharmaceutical Market: An Overview
2.1 Market Size & Growth
2.2 Geographical Performance
2.3 Leading Therapy Classes
2.4 Leading Drugs
2.5 Leading Pharmaceutical Companies
3. Market by Region
3.1 North America
3.1.1 US
3.1.2 Canada
3.2 Latin America
3.2.1 Brazil
3.2.2 Mexico
3.2.3 Argentina
3.2.4 Chile
3.3 Europe
3.3.1 Germany
3.3.2 France
3.3.3 Italy
3.3.4 Spain
3.3.5 UK
3.3.6 Russia
3.3.7 Turkey
3.3.8 Poland
3.3.9 Hungary
3.3.10 Ukraine
3.3.11 Czech Republic
3.3.12 Romania
3.4 Asia-Pacific
3.4.1 India
3.4.2 China
3.4.3 Japan
3.4.4 South Korea
3.4.5 Indonesia
3.4.6 Vietnam
3.4.7 Thailand
3.4.8 Philippines
3.4.9 Malaysia
3.4.10 Saudi Arabia
3.4.11 UAE
3.4.12 Australia
3.4.13 New Zealand
3.5 Africa
3.5.1 South Africa
3.5.2 Egypt
3.5.3 Nigeria
4. Key Player Profiles
4.1 Pfizer Inc
4.2 Sanofi-Aventis
4.3 GlaxoSmithKline plc
4.4 Novartis International AG
4.5 AstraZeneca Plc
[Inhaltsverzeichnis ausblenden]

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2008
Figure 2-5: Global - Leading Pharmaceutical Companies by Sales (Billion US$), 2008
Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-3: US - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2007-2009
Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2010-2012
Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-15: Chile - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-16: Chile - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-19: Germany - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-20: Germany - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-21: France - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-22: France - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-23: Italy - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-24: Italy - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-25: Spain - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-26: Spain - Share of Prescription & OTC Drugs in Pharmaceutical Market (2008)
Figure 3-27: Spain - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-28: UK - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-29: UK - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-30: Russia - Pharmaceutical Market (Billion Rubles), 2007-2009
Figure 3-31: Russia - Share of Commercial & State Sector in Pharmaceutical Market (2008)
Figure 3-32: Russia - Share of Imported & Domestically-produced Drugs in Pharmaceutical Market (2008)
Figure 3-33: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2010-2012
Figure 3-34: Turkey - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-35: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 3-36: Turkey - Share of Therapy Areas in Pharmaceutical Market (2008)
Figure 3-37: Turkey - Share of Imported & Domestically-produced Drugs in Pharmaceutical Market (2008)
Figure 3-38: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-39: Poland - Pharmaceutical Market (Billion €), 2007-2009
Figure 3-40: Poland - Forecast for Pharmaceutical Market (Billion €), 2010-2012
Figure 3-41: Hungary - Pharmaceutical Market (Million €), 2007-2009
Figure 3-42: Hungary - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-43: Ukraine - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-44: Ukraine - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-45: Czech Republic - Pharmaceutical Market (Million €), 2007-2009
Figure 3-46: Czech Republic - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-47: Romania - Pharmaceutical Market (Million €), 2007-2009
Figure 3-48: Romania - Forecast for Pharmaceutical Market (Million €), 2010-2012
Figure 3-49: Asia-Pacific - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-50: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-51: India - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-52: India - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-53: China - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-54: China - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-55: Japan - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-56: Japan - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-57: South Korea - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-58: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-59: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2009
Figure 3-60: Indonesia - Forecast for Pharmaceutical Market (Trillion Rp), 2010-2012
Figure 3-61: Vietnam - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-62: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-63: Thailand - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-64: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-65: Philippines - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-66: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-67: Malaysia - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-68: Malaysia - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-69: Saudi Arabia - Pharmaceutical Market (Billion SR), 2007-2009
Figure 3-70: Saudi Arabia - Sales of Imported & Domestically-produced Pharmaceuticals (Billion SR), 2004-2007
Figure 3-71: Saudi Arabia - Forecast for Pharmaceutical Market (Billion SR), 2010-2012
Figure 3-72: UAE - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-73: UAE - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 3-74: Australia - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-75: Australia - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-76: New Zealand - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-77: New Zealand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-78: South Africa - Pharmaceutical Market (Billion ZAR), 2007-2009
Figure 3-79: South Africa - Forecast for Pharmaceutical Market (Billion ZAR), 2010-2012
Figure 3-80: Egypt - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-81: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-82: Nigeria - Pharmaceutical Market (Million US$), 2007-2009
Figure 3-83: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2010-2012

List of Tables:

Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2008
Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2008
Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2008
Table 3-1: US - Healthcare Statistics (2007-2009)
Table 3-2: US - Forecast for Healthcare Statistics (2010-2012)
Table 3-3: Canada - Healthcare Statistics (2007-2009)
Table 3-4: Canada - Forecast for Healthcare Statistics (2010-2012)
Table 3-5: Brazil - Healthcare Statistics (2007-2009)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2010-2012)
Table 3-7: Mexico - Healthcare Statistics (2007-2009)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2010-2012)
Table 3-9: Argentina - Healthcare Statistics (2007-2009)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2010-2012)
Table 3-11: Chile - Healthcare Statistics (2007-2009)
Table 3-12: Chile - Forecast for Healthcare Statistics (2010-2012)
Table 3-13: Germany - Healthcare Statistics (2007-2009)
Table 3-14: Germany - Forecast for Healthcare Statistics (2010-2012)
Table 3-15: France - Healthcare Statistics (2007-2009)
Table 3-16: France - Forecast for Healthcare Statistics (2010-2012)
Table 3-17: Italy - Healthcare Statistics (2007-2009)
Table 3-18: Italy - Forecast for Healthcare Statistics (2010-2012)
Table 3-19: Spain - Healthcare Statistics (2007-2009)
Table 3-20: Spain - Forecast for Healthcare Statistics (2010-2012)
Table 3-21: UK - Healthcare Statistics (2007-2009)
Table 3-22: UK - Forecast for Healthcare Statistics (2010-2012)
Table 3-23: Russia - Healthcare Statistics (2007-2009)
Table 3-24: Russia - Forecast for Healthcare Statistics (2010-2012)
Table 3-25: Turkey - Healthcare Statistics (2007-2009)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2010-2012)
Table 3-27: Poland - Healthcare Statistics (2007-2009)
Table 3-28: Poland - Forecast for Healthcare Statistics (2010-2012)
Table 3-29: Hungary - Healthcare Statistics (2007-2009)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2010-2012)
Table 3-31: Ukraine - Healthcare Statistics (2007-2009)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2010-2012)
Table 3-33: Czech Republic - Healthcare Statistics (2007-2009)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2010-2012)
Table 3-35: Romania - Healthcare Statistics (2007-2009)
Table 3-36: Romania - Forecast for Healthcare Statistics (2010-2012)
Table 3-37: India - Healthcare Statistics (2007-2009)
Table 3-38: India - Forecast for Healthcare Statistics (2010-2012)
Table 3-39: China - Healthcare Statistics (2007-2009)
Table 3-40: China - Forecast for Healthcare Statistics (2010-2012)
Table 3-41: Japan - Healthcare Statistics (2007-2009)
Table 3-42: Japan - Forecast for Healthcare Statistics (2010-2012)
Table 3-43: South Korea - Healthcare Statistics (2007-2009)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2010-2012)
Table 3-45: Indonesia - Healthcare Statistics (2007-2009)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2010-2012)
Table 3-47: Vietnam - Healthcare Statistics (2007-2009)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2010-2012)
Table 3-49: Thailand - Healthcare Statistics (2007-2009)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2010-2012)
Table 3-51: Philippines - Healthcare Statistics (2007-2009)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2010-2012)
Table 3-53: Malaysia - Healthcare Statistics (2007-2009)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2010-2012)
Table 3-55: Saudi Arabia - Healthcare Statistics (2007-2009)
Table 3-56: Saudi Arabia - Forecast for Healthcare Statistics (2010-2012)
Table 3-57: Australia - Healthcare Statistics (2007-2009)
Table 3-58: Australia - Forecast for Healthcare Statistics (2010-2012)
Table 3-59: New Zealand - Healthcare Statistics (2007-2009)
Table 3-60: New Zealand - Forecast for Healthcare Statistics (2010-2012)
Table 3-61: South Africa - Healthcare Statistics (2007-2009)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2010-2012)
Table 3-63: Egypt - Healthcare Statistics (2007-2009)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2010-2012)
Table 3-65: Nigeria - Healthcare Statistics (2007-2009)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2010-2012)
Table 4-1: Pfizer Inc - Strengths & Weaknesses
Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-4: Novartis International AG - Strengths & Weaknesses
Table 4-5: AstraZeneca Plc - Strengths & Weaknesses
[Tabellenverzeichnis ausblenden]